Edwards Lifesciences Average Equity Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 114.67  1.59  1.41%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Average Equity of Edwards Lifesciences Corporation with missing and latest data points interpolated. Average equity value for the period used in calculation of Return on Average Equity, derived from Shareholders Equity.
Average Equity  10 Years Trend  
Increasing
Slightly volatile
 Average Equity 
      Timeline 

Edwards Lifesciences Average Equity Over Time

2015-12-31  2,356,750,000 
2016-12-31  2,520,325,000 
2017-12-31  2,566,881,579 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  1,502,752,632
Geometric Mean  1,340,013,781
Coefficient Of Variation  46.54
Mean Deviation  556,869,737
Median  1,460,125,000
Standard Deviation  699,420,562
Range  2,129,131,579
R Value  0.98
R Squared  0.97
Significance  0.00000001
Slope  190,607,683

Currently Trending

AJRD   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 34.4
I   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 6.4
CBAY   
 NCM 
Purchased over 90 shares of
few hours ago ago
Traded for 8.14